By Amir Orusov and Anastasiia Kozlova
Nov 12 (Reuters) – Swiss hearing-aid maker Sonova on Thursday raised its sales and profit guidance for fiscal 2027, citing gains in market share and solid uptake of new products.
The world’s largest maker of hearing aids now expects sales to rise by 6% to 8% in local currency, up from a previous forecast of 5% to 8%, and core operating profit to grow 10% to 13%, compared with an earlier outlook of 7% to 10%, in the year through March 2027.
The upgrade comes as demand across the hearing-aid industry remains robust and provides an early indication of the commercial success of Sonova’s AI-powered Phonak EON platform, seen as a key driver of its medium-term growth targets.
“EON is already contributing above our expectations,” CEO Eric Bernard said in a statement, adding that the rollout of the platform across markets had supported both growth and market-share gains.
Rival Demant raised its full-year guidance for the second time this year in October, helped by stronger growth and a favourable product mix.
Sonova now expects the global hearing-aid market to grow 3% to 5% this year, up from a previous forecast of 2% to 4%.
Investors are also watching Sonova’s expansion in Asia-Pacific, which the company sees as a key long-term growth market due to low hearing-aid penetration, ageing populations and rising incomes.
Sales in Asia-Pacific rose 11.4% to 186.9 million francs in the first half of the fiscal year, driven by mid-teens growth in the group’s core Hearing Instruments business, particularly in Australia, China and Japan.
(Reporting by Amir Orusov and Anastasiia Kozlova; Editing by Sahal Muhammed)
